Additionally, levels of soluble FcRH5 are known to be elevated in the blood of multiple myeloma patients6, and this shed form of FcRH5 may have resulted in decreased binding of DFRF4539A to membrane-bound FcRH5. Here, FCRL5 is linked to AL amyloidosis.